NCT07090499 2026-03-19A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid TumorsPfizerPhase 1 Recruiting310 enrolled
NCT04140500 2026-03-18Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid TumorsHoffmann-La RochePhase 1/2 Active not recruiting170 enrolled
NCT04389632 2026-03-16A Study of Sigvotatug Vedotin in Advanced Solid TumorsSeagen Inc.Phase 1 Recruiting1,006 enrolled
NCT07229313 2026-03-10A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid TumorsKivu Bioscience Inc.Phase 1 Recruiting76 enrolled
NCT06047379 2026-03-02Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisNeonc Technologies, Inc.Phase 1/2 Recruiting134 enrolled
NCT05208762 2026-02-23A Study of PF-08046054/SGN-PDL1V in Advanced Solid TumorsSeagen Inc.Phase 1 Recruiting714 enrolled